Correlation Between DiaMedica Therapeutics and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Citius Oncology,, you can compare the effects of market volatilities on DiaMedica Therapeutics and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Citius Oncology,.
Diversification Opportunities for DiaMedica Therapeutics and Citius Oncology,
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between DiaMedica and Citius is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Citius Oncology, go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Citius Oncology,
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.34 times more return on investment than Citius Oncology,. However, DiaMedica Therapeutics is 2.91 times less risky than Citius Oncology,. It trades about 0.05 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.19 per unit of risk. If you would invest 343.00 in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of 191.00 from holding DiaMedica Therapeutics or generate 55.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 25.48% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Citius Oncology,
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Citius Oncology, |
DiaMedica Therapeutics and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Citius Oncology,
The main advantage of trading using opposite DiaMedica Therapeutics and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Citius Oncology, vs. Connect Biopharma Holdings | Citius Oncology, vs. Acumen Pharmaceuticals | Citius Oncology, vs. Nuvation Bio | Citius Oncology, vs. Eledon Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |